- Slingshot Biosciences and Cellares have entered a strategic collaboration to integrate Slingshot’s TruCytes™ Biomarker controls into Cellares’ automated QC testing platform, Cell Q™.
- The partnership aims to enhance precision, consistency, and scalability in automated quality control for cell therapy manufacturing.
Slingshot Biosciences, a company specialising in precision-engineered cell mimic controls, has announced a strategic collaboration with Cellares, the first Integrated Development and Manufacturing Organization (IDMO). The partnership will integrate Slingshot’s TruCytes™ Biomarker controls into Cellares’ Cell Q™, the industry’s first fully automated quality-control (QC) testing platform designed to scale with the Cell Shuttle™, Cellares’ automated manufacturing system recognised by the U.S. FDA under the Advanced Manufacturing Technology (AMT) programme.
TruCytes biomarker controls represent a major advance in standardised reference materials for flow cytometry. They replicate the optical and biochemical properties of real cells without donor-to-donor variability, ensuring precision and reproducibility in analytical workflows. Their integration within Cellares’ QC system aims to reduce failure rates, enhance data consistency, and streamline production processes across multiple sites.
“Slingshot’s TruCytes controls provide standardised, ready-to-run inputs for QC across instruments and sites, eliminating the variability and supply constraints that come with donor-based materials. Integrating them into our Cell Q platform extends the same level of automation, reliability, and traceability that define the Cell Shuttle.”
Fabian Gerlinghaus, CEO and Co-Founder of Cellares
According to Slingshot Biosciences CEO Glenn Bilawsky, the collaboration aligns with the growing complexity of flow cytometry technologies and the need for robust, automated solutions. He stated that integrating TruCytes with automated QC enables continuous and reliable testing at an industrial scale, addressing the demands of global cell therapy manufacturing.
